Nicotinell Mint Spray Buccal

Nicotine, the active ingredient in Nicotinell Mint Spray Buccal, is a nicotinic receptor agonist presented as a buccal spray for oromucosal use. It helps adult smokers who want to quit by reducing nicotine withdrawal symptoms and cravings.

GNH USA supplies Nicotinell Mint Spray Buccal as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell Mint Spray Buccal, a nicotinic receptor agonist, is used in smoking cessation to alleviate nicotine withdrawal.

- Smoking cessation: assists adult smokers in reducing cravings and withdrawal when quitting. - Tobacco dependence: supports gradual reduction of nicotine intake for dependent users. - Nicotine withdrawal: mitigates symptoms such as irritability, anxiety, and difficulty concentrating during abstinence.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Throat irritation: transient discomfort or scratchiness. - Hiccups: occasional involuntary diaphragmatic contractions. - Nausea: mild upset stomach after use. - Dizziness: brief light‑headed sensation. - Cough: transient irritation leading to cough.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention. - Severe mouth ulceration: persistent lesions in the buccal mucosa. - Cardiovascular events: increased heart rate or blood pressure in susceptible individuals. - Seizures: rare neurologic events reported with excessive nicotine exposure.

Before using Nicotinell Mint Spray Buccal, consider the following precautions. - Pregnancy: safety not established; avoid unless benefits outweigh potential risks. - Breastfeeding: unknown effects on infant; consider alternative cessation methods. - Cardiovascular disease: use with caution; monitor heart rate and blood pressure. - Respiratory disorders: may provoke bronchospasm in asthma or COPD patients. - Age restriction: not intended for individuals under 18 years of age. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Nicotinell Mint Spray Buccal may interact with other medicines as follows.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): can amplify nicotine’s sympathomimetic effects. - CYP2A6 inhibitors: may increase systemic nicotine levels. - Concurrent nicotine replacement therapies: risk of nicotine overdose.

Moderate Interactions (Monitor Closely): - Caffeine: nicotine may enhance stimulant effects, leading to jitteriness. - Beta‑blockers: nicotine may reduce antihypertensive efficacy. - Antidepressants (SSRIs): monitor for increased anxiety or insomnia.